Literature DB >> 14617748

Therapeutic CD154 antibody for lupus: promise for the future?

Garnett Kelsoe1.   

Abstract

Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease characterized by the production of pathogenic autoantibodies. A new study demonstrates that passive antibody specific for the TNF family member, CD154, ameliorates disease by reducing levels of self-reactive antibody in the serum. This study demonstrates a substantial potential for anti-CD154 antibody in the treatment of humoral autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617748      PMCID: PMC259140          DOI: 10.1172/JCI20371

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis.

Authors:  H J Kim; V Krenn; G Steinhauser; C Berek
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

2.  Cutting edge: germinal centers can be induced in the absence of T cells.

Authors:  V M Lentz; T Manser
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position.

Authors:  Karin Reif; Eric H Ekland; Lars Ohl; Hideki Nakano; Martin Lipp; Reinhold Förster; Jason G Cyster
Journal:  Nature       Date:  2002-03-07       Impact factor: 49.962

4.  Spontaneous formation of germinal centers in autoimmune mice.

Authors:  I G Luzina; S P Atamas; C E Storrer; L C daSilva; G Kelsoe; J C Papadimitriou; B S Handwerger
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

5.  Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.

Authors:  E Arce; D G Jackson; M A Gill; L B Bennett; J Banchereau; V Pascual
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

6.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

7.  Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers.

Authors:  Kai-Michael Toellner; William E Jenkinson; Dale R Taylor; Mahmood Khan; Daniel M-Y Sze; David M Sansom; Carola G Vinuesa; Ian C M MacLennan
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

8.  Germinal centers without T cells.

Authors:  C G de Vinuesa; M C Cook; J Ball; M Drew; Y Sunners; M Cascalho; M Wabl; G G Klaus; I C MacLennan
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

9.  Virus-induced maturation and activation of autoreactive memory B cells.

Authors:  A J Reed; M P Riley; A J Caton
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

Review 10.  Revising B cell receptors.

Authors:  D Nemazee; M Weigert
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  4 in total

Review 1.  The CD40/CD40L costimulatory pathway in inflammatory bowel disease.

Authors:  S Danese; M Sans; C Fiocchi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

2.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment.

Authors:  Qu Lin; Zhiming Lin; Jieruo Gu; Feng Huang; Tianwang Li; Qiujing Wei; Zetao Liao; Shuangyan Cao; Yingjuan Jiang; Jinxian Huang
Journal:  Rheumatol Int       Date:  2009-05-23       Impact factor: 2.631

4.  Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus.

Authors:  Ramya Sivakumar; Georges Abboud; Clayton E Mathews; Mark A Atkinson; Laurence Morel
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.